Welcome to LookChem.com Sign In|Join Free

CAS

  • or

2275-14-1

Post Buying Request

2275-14-1 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

2275-14-1 Usage

Safety Profile

Poison by ingestion. Moderately toxic by skin contact. A cholinesterase inhibitor. When heated to decomposition it emits very toxic fumes of Cl-, POx, and SOx. See also PARATHION

Check Digit Verification of cas no

The CAS Registry Mumber 2275-14-1 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 2,2,7 and 5 respectively; the second part has 2 digits, 1 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 2275-14:
(6*2)+(5*2)+(4*7)+(3*5)+(2*1)+(1*4)=71
71 % 10 = 1
So 2275-14-1 is a valid CAS Registry Number.
InChI:InChI=1/C11H15Cl2O2PS3/c1-3-14-16(17,15-4-2)19-8-18-11-7-9(12)5-6-10(11)13/h5-7H,3-4,8H2,1-2H3

2275-14-1SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 17, 2017

Revision Date: Aug 17, 2017

1.Identification

1.1 GHS Product identifier

Product name phenkapton

1.2 Other means of identification

Product number -
Other names (2,5-dichlorophenyl)sulfanylmethylsulfanyl-diethoxy-sulfanylidene-λ<sup>5</sup>-phosphane

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:2275-14-1 SDS

2275-14-1Downstream Products

2275-14-1Relevant articles and documents

Method for isolating sponge collagen and producing nanoparticulate collagen, and the use thereof

-

, (2008/06/13)

The invention relates to a method for the simplified isolation in high yields of sponge collagen, especially from marine sponges, and to the production of collagen nanoparticles from collagen. The invention further relates to the use thereof for influencing cell-dependent processes in vitro and in vivo, especially when orally or topically administered to treat inflammatory, preferably cyclooxygenase-dependent diseases.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 2275-14-1